Table 4.
Univariate analysis of CSF biomarkers and genetic pattern at baseline for FoG onset during the 5-year follow up
| Index | OR | 95% CI | P | |
|---|---|---|---|---|
| CSF biomarkers | ||||
| Abeta | 1.00 | 1.00 | 1.00 | 0.027* |
| Tau | 1.00 | 0.99 | 1.00 | 0.622 |
| pTau | 1.00 | 0.94 | 1.06 | 0.885 |
| aSyn | 1.00 | 1.00 | 1.00 | 0.653 |
| Genetic Pattern | ||||
| APOE | 0.94 | 0.64 | 1.40 | 0.775 |
| APOE Genotype—number of e4 alleles | 0.87 | 0.48 | 1.60 | 0.663 |
| SNCA_rs3910105 | 1.35 | 0.86 | 2.12 | 0.194 |
| SNCA_rs356181 | 0.96 | 0.63 | 1.44 | 0.826 |
| MAPT | 0.96 | 0.57 | 1.61 | 0.865 |
In the regression analysis, different genetic features were represented as numbers as below:
APOE: e2/e4 ~ 1, e3/e2 ~ 2, e3/e3 ~ 3, e4/e3 ~ 4, e4/e4 ~ 5, e2/e2 ~ 6
SNCA_rs356181: C/C ~ 1, C/T ~ 2, T/T ~ 3
SNCA_rs3910105: C/C ~ 1, C/T ~ 2, T/T ~ 3
MAPT: H1/H1 ~ 1, H1/H2 ~ 2, H2/H2 ~ 3
P <0.05 was presented with ‘*’